1. Ackermann, M., Verleden, S.E., Kuehnel, M., et al., Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19, N. Engl. J. Med., 2020, vol. 383, no. 2, pp. 120–128.
2. Agrati, Ch., Bordoni, V., Sacchi, A., et al., Elevated P-selectin in severe Covid-19: considerations for therapeutic options, Mediterr. J. Hematol. Infect. Dis., 2021a, vol. 13, no. 1, art. ID e2021016.
3. Agrati, Ch., Sacchi, A., Tartaglia, E., et al., The role of P‑selectin in COVID-19 coagulopathy: an epidated review, Int. J. Mol. Sci., 2021b, vol. 22, no. 15, art. ID 7942.
4. Avdushkina, L.A., Bychkova, N.V., and Vavilova, T.V., New platelet activation marker P-selectin, Nikiforovskie chteniya – 2012: peredovye otechestvennye i zarubezhnye meditsinskie tekhnologii (Nikiforov Readings—2012: Advanced Domestic and Foreign Medical Technologies), Aleksanin, S.S., Ed., St. Petersburg: Politekhnika-servis, 2012, pp. 10–11.
5. Baigent, C., Blackwell, L., Collins, R., et al., Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 2009, vol. 373, pp. 1849–1860.